September 2017

O.T.- Reducing Risk:The Evolution of the Tobacco, Marijuana & Vaping Industries & their Role in Harm Reduction in Canada

11:30am-1:30pm | Fairmont Chateau Laurier - 1 Rideau Street, Ottawa

With Canada committing to the legalization of marijuana in 2018, and Bills C45 and S5 in parliament, the marijuana, tobacco and vaping industries have become top of mind for most Canadians. At the same time, the topic of harm reduction for Canadian consumers has become a critical priority, and an era of new thinking that goes beyond traditional regulations and approaches is becoming needed. By advocating for reduced risk products and providing education around effective harm reduction strategies, the marijuana, vaping and tobacco industries possess the potential to meaningfully improve an area of public health impacting many Canadians across the country.

Join us as some of the industry’s leading experts discuss how to create a better tomorrow by bringing a unique and important perspective to the discussion of harm reduction.

- Lunch will be served -

Member price:
Individual seat: $89 +HST
Table (seats 10): $800 +HST

Regular price:
Individual seat: $110 +HST
Table (seats 10): $990 +HST

- For information about accessibility, please email lapointe@economicclub.ca
- Dietary restriction notes and meal requests must be submitted to lapointe@economicclub.ca by Monday, September 18, 2017

Colette Rivet

Executive Director
Cannabis Canada Association

Colette Rivet

Colette Rivet is an experienced association leader with a deep background in health matters, having been a senior health professional within hospitals and having served previously as Executive Director of non-profits such as BioTalent Canada, in addition to senior roles within the Canadian Centre on Substance Abuse (CCSA), the Canadian Institutes of Health Research (CIHR), the Royal College of Physicians and Surgeons of Canada, and the Canadian Blood Agency. Fluently bilingual, Ms. Rivet has a Masters of Business Administration from the University of Ottawa. She has the experience, insight and drive to lead the Association’s initiatives to protect and enhance Canada’s national medical cannabis system, and to bring our members’ vast expertise to the public policy discussions around legalization of non-medical cannabis.

David Sweanor

Adjunct Professor, Faculty of Law, University of Ottawa
Honorary (Consultant) Assistant Professor, University of Nottingham

David Sweanor

David is an adjunct professor of law, and chair of the advisory committee for the Centre for Health Law, Policy and Ethics, at the University of Ottawa, and Honorary (Consultant) Assistant Professor, University of Nottingham.

He helped spearhead the development of world-leading tobacco control initiatives in Canada starting in the early 1980s, first as counsel to the Non-Smokers Rights Association and then as an independent consultant. His global work has included litigation against cigarette companies and assistance to the World Bank and World Health Organization.

His interest has focused on the interaction of law and economics as a determinant of public health. He has worked on tax policy, contraband tobacco, litigation strategies, risk communication and the provision of less hazardous alternatives to existing products. Since many alternative nicotine products have comparatively minor risks, risk reduction principles that have been applied very widely and very successfully on other issues have enormous potential to tremendously reduce the current global epidemic of smoking-caused death and disease.

He has been widely published in peer-reviewed scientific journals, including the New England Journal of Medicine and JAMA, testified before parliamentary committees in Canada and elsewhere, and before both Senate and House committees in the United States. He has received various awards for his work, including a ‘Public Health Hero’ lifetime achievement award from the Pan-American Health Organization.

His work, both personally and through philanthropic funding, extends to a wide range of other issues, including international development, healthy cities, nutrition, prison reform, illicit drugs, human rights, education and physical activity. In November 2016, he was the recipient of Ottawa’s Outstanding Individual Philanthropist award.

Marc Kealey

Lead Advocate
Canadian Vaping Association

Marc Kealey

With over 30 years of experience in public policy, advocacy and management Marc Kealey is a leading voice for transformation in health - most notably in prescription drug reform, healthcare delivery, smoking cessation and medical human resource management.

He is the lead advocate for Canadian Vaping Association (CVA), which advocates for vape product shop owners and their employees, manufacturers of e-liquid for the vape industry and the hundreds of thousands of Canadians who have chosen vaping as an alternative to combustible tobacco products. His efforts have had direct impact on legislative initiatives in almost every province in Canada and with the Government of Canada on its recent Bill S-5 legislation that recognizes vaping as a less harmful alternative to smoking cigarettes.

He speaks at conference and is often seen on media throughout North America and globally on issues related to vaping and its harm reduction benefit. He is the Chief Advocate at K&A Inc., a public policy and management consultancy.

Marni Soupcoff

Writer, Commentator & Policy Analyst

Marni Soupcoff

Marni Soupcoff is a writer, commentator, and policy analyst, with a particular interest in and focus on education and health. Her writing appears in the National Post and Regulation magazine. Her work has previously appeared in the Washington Post, the New York Post, the Stanford Journal of International Law and other publications.

Marni is a fourth generation Torontonian, but spent nine years in the United States, where she graduated Phi Beta Kappa from the Johns Hopkins University in 1997 and received her law degree from Stanford University in 2000. Before moving back to Toronto, Marni worked as a lawyer with the Institute for Justice, where she litigated economic liberty and property rights cases. She has been a member of the District of Columbia bar since 2000.

Peter Luongo

Managing Director
Rothmans, Benson & Hedges Inc.

Peter Luongo

Peter Luongo is the Managing Director of Rothmans, Benson & Hedges Inc. (RBH). Before joining RBH in December 2016, Mr. Luongo was Vice President, Treasury and Planning for Philip Morris International in Lausanne, where he oversaw the global treasury, strategy and business planning functions for the company.

Prior to assuming his position at Philip Morris in June 2013, Mr. Luongo was a partner at the investment banking firm of Centerview Partners LLC, where he had served since 2004. He has extensive experience in advising international clients across a range of sectors on mergers and acquisitions as well as other financial, strategic and investor matters.

Mr. Luongo holds a Bachelor degree in Economics from Princeton University.

Our Sponsors

Telus Interac Green Shield Canada